The nuclear receptor AHR e.g. has been shown to promote retinoic acid–induced differentiation of HL-60 myeloblastic leukemia cells, if overexpressed [40] while AHR knockout mice are diagnosed with CML [51]. Here, AHR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.